2019
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension
Beaney T, Burrell L, Castillo R, Charchar F, Cro S, Damasceno A, Kruger R, Nilsson P, Prabhakaran D, Ramirez A, Schlaich M, Schutte A, Tomaszewski M, Touyz R, Wang J, Weber M, Poulter N, Burazeri G, Qirjako G, Roshi E, Cunashi R, Fernandes M, Pereira S, Neto M, Oliveira P, Feijão A, Cerniello Y, Marin M, Vasquez F, Espeche W, Stisman D, Fuentes I, Zilberman J, Rodriguez P, Babinyan K, Engibaryan A, Avagyan A, Minasyan A, Gevorkyan A, Carnagarin R, Carrington M, Sharman J, Lee R, Perl S, Niederl E, Malik F, Choudhury S, Al Mamun M, Ishraquzzaman M, Anthony F, Connell K, De Backer T, Krzesinski J, Houenassi M, Houehanou C, Sokolovic S, Bahtijarevic R, Tiro M, Mosepele M, Masupe T, Barroso W, Gomes M, Feitosa A, Brandão A, Miranda R, Azevedo V, Dias L, Garcia G, Martins I, Dzudie A, Kingue S, Djomou F, Njume E, Khan N, Lanas F, Garcia M, Paccot M, Torres P, Li Y, Liu M, Xu L, Li L, Chen X, Deng J, Zhao W, Fu L, Zhou Y, Lopez-Jaramillo P, Otero J, Camacho P, Accini J, Sanchez G, Arcos E, M’Buyamba-Kabangu J, Katamba F, Ngoyi G, Buila N, Bayauli P, Mbolla B, Bakekolo P, Landa C, Kaky G, Kramoh E, Ngoran Y, Olsen M, Valoy L, Santillan M, Rafael G, Peñaherrera C, Villalba J, Ramirez M, Arteaga F, Delgado P, Beistline H, Cappuccio F, Keitley J, Tay T, Goshu D, Kassie D, Gebru S, Pathak A, Denolle T, Tsinamdzgvrishvili B, Trapaidze D, Sturua L, Abesadze T, Grdzelidze N, Grabfelder M, Krämer B, Schmeider R, Twumasi-Ankrah B, Tannor E, Lincoln M, Deku E, Quintana F, Kenerson J, Baptiste E, Saintilmond W, Barrientos A, Peiger B, Lagos A, Forgas M, Lee V, Tomlinson B, Járai Z, Páll D, More A, Maheshwari A, Verma N, Sharma M, Mukherjee T, Patil M, Jose A, More A, Takalkar A, Turana Y, Widyantoro B, Danny S, Djono S, Handari S, Tambunan M, Tiksnadi B, Hermiawaty E, Tavassoli E, Zolfaghari M, Dolan E, O'Brien E, Borghi C, Ferri C, Torlasco C, Parati G, Nwokocha C, Nwokocha M, Ogola E, Gitura B, Barasa A, Barasa F, Wairagu A, Nalwa W, Najem R, Abu Alfa A, Fageh H, Msalam O, Derbi H, Bettamar K, Zakauskiene U, Vickiene A, Calmes J, Alkerwi A, Gantenbein M, Ndhlovu H, Masiye J, Chirwa M, Nyirenda N, Dhlamini T, Chia Y, Ching S, Devaraj N, Ouane N, Fane T, Kowlessur S, Ori B, Heecharan J, Alcocer L, Chavez A, Ruiz G, Espinosa C, Gomez-Alvarez E, Neupane D, Bhattarai H, Ranabhat K, Adhikari T, Koirala S, Toure I, Soumana K, Wahab K, Omotoso A, Sani M, Okubadejo N, Nadar S, Al-Riyami H, Ishaq M, Memon F, Sidique S, Choudhry H, Khan R, Ayala M, Maidana A, Bogado G, Ona D, Atilano A, Granada C, Bartolome R, Manese L, Mina A, Dumlao M, Villaruel M, Gomez L, Jóźwiak J, Małyszko J, Banach M, Mastej M, de Carvalho Rodrigues M, Martins L, Paval A, Dorobantu M, Konradi A, Chazova I, Rotar O, Spoares M, Viegas D, Almustafa B, Alshurafa S, Brady A, Bovet P, Viswanathan B, Oladapo O, Russell J, Brguljan-Hitij J, Bozic N, Knez J, Dolenc P, Hassan M, Woodiwiss A, Myburgh C, Vally M, Ruilope L, Molinero A, Rodilla E, Gijón-Conde T, Beheiry H, Ali I, Osman A, fahal N, Osman H, Altahir F, Persson M, Wuerzner G, Burkard T, Wang T, Lin H, Pan H, Chen W, Lin E, Mondo C, Ingabire P, Khomazyuk T, Krotova V, Negresku E, Evstigneeva O, Bazargani N, Agrawal A, Bin Belaila B, Suhail A, Muhammed K, Shuri H, Wainford R, Levy P, Boggia J, Garré L, Hernandez-Hernandez R, Octavio-Seijas J, Lopez-Rivera J, Morr I, Duin A, Huynh M, Cao S, Nguyen V, To M, Phan H, Cockroft J, McDonnell B, Goma F, Syatalimi C, Chifamba J, Gwini R, Tiburcio O, Xia X. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. European Heart Journal 2019, 40: 2006-2017. PMID: 31041440, PMCID: PMC6600128, DOI: 10.1093/eurheartj/ehz300.Peer-Reviewed Original ResearchConceptsMay Measurement MonthBlood pressureAntihypertensive medicationsMeasurement MonthDiastolic blood pressureSystolic blood pressureHigh blood pressureSystematic screening programmeMore participantsMMM 2018Untreated hypertensionBP readingsFormal screeningBP measurementsDisease burdenMultiple imputationHypertensionScreening programMedicationsMmHgInternational SocietyMonthsScreening campaignParticipantsIndividuals
2015
Hypertensive Encephalopathy and Renal Failure in a Young Man
Hunter RW, Dominiczak AF, Alwakeel J, Staessen JA, Jennings GL, Abu-Alfa AK, Webb DJ, Dhaun N. Hypertensive Encephalopathy and Renal Failure in a Young Man. Hypertension 2015, 67: 6-13. PMID: 26597825, DOI: 10.1161/hypertensionaha.115.06651.Peer-Reviewed Case Reports and Technical Notes
2012
Non-Uremic Calcific Arteriolopathy (Calciphylaxis) in Relapsed/Refractory Hodgkin's Lymphoma: A Previously Unreported Association
Sibai H, Ishak RS, Halawi R, Otrock ZK, Salman S, Abu-Alfa A, Kharfan-Dabaja MA. Non-Uremic Calcific Arteriolopathy (Calciphylaxis) in Relapsed/Refractory Hodgkin's Lymphoma: A Previously Unreported Association. Journal Of Clinical Oncology 2012, 30: e88-e90. PMID: 22231039, DOI: 10.1200/jco.2011.39.4551.Peer-Reviewed Case Reports and Technical Notes
2010
Experience with outpatient computed tomographic-guided renal biopsy.
Margaryan A, Perazella MA, Mahnensmith RL, Abu-Alfa AK. Experience with outpatient computed tomographic-guided renal biopsy. Clinical Nephrology 2010, 74: 440-5. PMID: 21084047, DOI: 10.5414/cnp74440.Peer-Reviewed Original ResearchConceptsNative kidney biopsiesKidney biopsyRenal biopsyPost-biopsy observation periodInpatient observation periodObservation periodLow complication rateTime of admissionYale-New Haven Medical CenterDuration of procedureInstances of deathHemoglobin concentration changesDetectable bleedingSerum creatinineComplication rateMean ageRenal sizeAdequate tissueMedical CenterOutpatient unitDiagnostic tissueBiopsyLaboratory dataTransfusionPatients
2009
Gadolinium‐containing magnetic resonance image contrast agent promotes fibrocyte differentiation
Vakil V, Sung JJ, Piecychna M, Crawford JR, Kuo P, Abu‐Alfa A, Cowper SE, Bucala R, Gomer RH. Gadolinium‐containing magnetic resonance image contrast agent promotes fibrocyte differentiation. Journal Of Magnetic Resonance Imaging 2009, 30: 1284-1288. PMID: 19937928, PMCID: PMC2787835, DOI: 10.1002/jmri.21800.Peer-Reviewed Original ResearchConceptsPeripheral blood mononuclear cellsNephrogenic systemic fibrosisSerum amyloid PFibrocyte differentiationDifferentiation of monocytesNSF patientsBlood mononuclear cellsHemodialysis patientsInterleukin-12Mononuclear cellsPurified monocytesFibroblast-like cellsFibrotic lesionsHealthy controlsSystemic fibrosisAmyloid PContrast agentsPatientsMonocytesDifferentiation inhibitorWiley-LissFibrocytesOmniscanDifferentiation protocolsCellsSuccessful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis
Huen SC, Hall I, Topal J, Mahnensmith RL, Brewster UC, Abu-Alfa AK. Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis. American Journal Of Kidney Diseases 2009, 54: 538-541. PMID: 19237231, DOI: 10.1053/j.ajkd.2008.12.017.Peer-Reviewed Case Reports and Technical NotesConceptsIntraperitoneal daptomycinPeritoneal dialysis-associated peritonitisDialysis-associated peritonitisEnterococcus faecium peritonitisSuch resistant organismsPeritoneal dialysis therapyTreatment of patientsVancomycin-resistant enterococciDialysis therapyDialysate exchangePeritonitisResistant organismsPatientsDaptomycinDextrose solutionAdditional studiesTreatmentSuccessful useRelapseDosingTherapyPharmacokineticsInfection
2007
Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis?
Saab G, Abu-Alfa A. Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis? Radiology 2007, 244: 930-932. PMID: 17709844, DOI: 10.1148/radiol.2443070351.Peer-Reviewed Original ResearchWill dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?
Saab G, Abu-Alfa A. Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration? American Journal Of Roentgenology 2007, 189: w169. PMID: 17715089, DOI: 10.2214/ajr.07.2252.Peer-Reviewed Original Research
2003
Addition of sertraline to other therapies to reduce dialysis‐associated hypotension
BREWSTER UC, CIAMPI MA, ABU‐ALFA A, PERAZELLA MA. Addition of sertraline to other therapies to reduce dialysis‐associated hypotension. Nephrology 2003, 8: 296-301. PMID: 15012700, DOI: 10.1111/j.1440-1797.2003.00216.x.Peer-Reviewed Original ResearchConceptsDialysis-associated hypotensionCentral blood volumePeripheral vascular resistanceBlood pressureCardiac outputBlood volumeEnd-stage renal disease patientsInitiation of dialysisRenal disease patientsDiastolic blood pressureSystolic blood pressureEffects of sertralineTermination of dialysisAddition of sertralineUltrasound dilution techniqueVascular resistanceArterial pressureHaemodynamic measurementsDisease patientsPatientsControl phaseSertralineTherapyDialysisHypotension
2002
Observations on HIV-Associated Renal Disease in the Era of Highly Active Antiretroviral Therapy
Cosgrove CJ, Abu-Alfa AK, Perazella MA. Observations on HIV-Associated Renal Disease in the Era of Highly Active Antiretroviral Therapy. The American Journal Of The Medical Sciences 2002, 323: 102-106. PMID: 11863077, DOI: 10.1097/00000441-200202000-00009.Peer-Reviewed Original ResearchConceptsHIV-associated nephropathyActive antiretroviral therapySerum creatinineRenal functionRenal diseaseRenal outcomesAntiretroviral therapyViral loadRenal lesionsHighly Active Antiretroviral TherapyAngiotensin-converting enzyme inhibitorEffect of HAARTNon-HAART groupAdvanced renal failureInitiation of dialysisRenal function parametersStable renal functionVariety of lesionsHAART groupCD4 countHAART eraRenal evaluationRenal insufficiencyRenal ultrasoundBaseline characteristicsHemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine
Hoeben H, Abu-Alfa AK, Mahnensmith R, Perazella MA. Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine. American Journal Of Kidney Diseases 2002, 39: 102-107. PMID: 11774108, DOI: 10.1053/ajkd.2002.29887.Peer-Reviewed Original ResearchConceptsPeripheral vascular resistanceCentral blood volumeDialysis-associated hypotensionCardiac outputIntradialytic hypotensionIntradialytic hemodynamicsCool dialysateEnd-stage renal disease populationTermination of hemodialysisInitiation of hemodialysisMean arterial pressureRenal disease populationUltrasound dilution techniqueVascular resistanceHemodynamic stabilityArterial pressureBlood pressureUltrafiltration volumeDisease populationHypotensionBlood volumePatientsMidodrineHemodialysisHemodynamics
1998
Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocol
Cayco A, Abu-Alfa A, Mahnensmith R, Perazella M. Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocol. American Journal Of Kidney Diseases 1998, 32: 302-308. PMID: 9708617, DOI: 10.1053/ajkd.1998.v32.pm9708617.Peer-Reviewed Original ResearchConceptsDynamic venous pressureHistorical control groupVenous pressureArteriovenous graftsSurveillance protocolStudy groupBlood flow rateThrombosis rateControl groupSimilar historical control groupHemodialysis vascular accessSynthetic arteriovenous graftsLower thrombosis rateML/minGraft impairmentVenous stenosisHD sessionVascular accessVascular stenosisPatientsScreening testStenosisStudy periodFrustrating problemConsecutive readings